- Home
- HCM vs IQ Comparison
HCM vs IQ Comparison
Compare HCM & IQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCM
- IQ
- Stock Information
- Founded
- HCM 2000
- IQ 2009
- Country
- HCM Hong Kong
- IQ China
- Employees
- HCM N/A
- IQ N/A
- Industry
- HCM Biotechnology: Pharmaceutical Preparations
- IQ Consumer Electronics/Video Chains
- Sector
- HCM Health Care
- IQ Consumer Discretionary
- Exchange
- HCM Nasdaq
- IQ Nasdaq
- Market Cap
- HCM 2.6B
- IQ 2.4B
- IPO Year
- HCM N/A
- IQ 2018
- Fundamental
- Price
- HCM $16.01
- IQ $2.45
- Analyst Decision
- HCM Sell
- IQ Strong Buy
- Analyst Count
- HCM 1
- IQ 5
- Target Price
- HCM $13.75
- IQ $2.61
- AVG Volume (30 Days)
- HCM 56.9K
- IQ 13.4M
- Earning Date
- HCM 08-07-2025
- IQ 11-20-2025
- Dividend Yield
- HCM N/A
- IQ N/A
- EPS Growth
- HCM N/A
- IQ N/A
- EPS
- HCM 0.53
- IQ 0.01
- Revenue
- HCM $602,197,000.00
- IQ $3,863,007,761.00
- Revenue This Year
- HCM N/A
- IQ N/A
- Revenue Next Year
- HCM $15.49
- IQ $3.85
- P/E Ratio
- HCM $5.91
- IQ $261.65
- Revenue Growth
- HCM N/A
- IQ N/A
- 52 Week Low
- HCM $11.51
- IQ $1.50
- 52 Week High
- HCM $21.50
- IQ $3.21
- Technical
- Relative Strength Index (RSI)
- HCM 48.16
- IQ 49.59
- Support Level
- HCM $17.19
- IQ $2.41
- Resistance Level
- HCM $16.35
- IQ $2.51
- Average True Range (ATR)
- HCM 0.29
- IQ 0.09
- MACD
- HCM -0.01
- IQ -0.05
- Stochastic Oscillator
- HCM 21.74
- IQ 17.19
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About IQ iQIYI Inc.
Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.